Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial

[1]  P. Rozance,et al.  Real‐time continuous glucose monitoring in preterm infants (react): An International, open‐label, randomised, controlled trial , 2021, Acta paediatrica.

[2]  M. Martín-González,et al.  Monitoring the incidence, duration and distribution of hyperglycaemia in very-low-birth-weight newborns and identifying associated factors , 2020, Journal of perinatal medicine.

[3]  G. Gamble,et al.  Glucose Profiles in Healthy Term Infants in the First 5 Days: The Glucose in Well Babies (GLOW) Study. , 2020, The Journal of pediatrics.

[4]  D. Dunger,et al.  Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants , 2019, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[5]  F. Doyle,et al.  Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range , 2019, Diabetes Care.

[6]  Darrell M. Wilson,et al.  A Feasibility Study to Detect Neonatal Hypoglycemia in Infants of Diabetic Mothers Using Real-Time Continuous Glucose Monitoring. , 2019, Diabetes technology & therapeutics.

[7]  M. Domellöf,et al.  Postnatal nutritional intakes and hyperglycemia as determinants of blood pressure at 6.5 years of age in children born extremely preterm , 2019, Pediatric Research.

[8]  D. Dunger,et al.  Targeting glucose control in preterm infants: pilot studies of continuous glucose monitoring , 2018, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[9]  I. Hansen‐Pupp,et al.  Hyperglycemia in Extremely Preterm Infants—Insulin Treatment, Mortality and Nutrient Intakes , 2018, The Journal of pediatrics.

[10]  D. Dunger,et al.  Protocol of a randomised controlled trial of real-time continuous glucose monitoring in neonatal intensive care ‘REACT’ , 2018, BMJ Open.

[11]  Benjamin Geiger,et al.  Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection , 2018, Science.

[12]  Eyal Dassau,et al.  International Consensus on Use of Continuous Glucose Monitoring , 2017, Diabetes Care.

[13]  J. Geoffrey Chase,et al.  Association of Neonatal Glycemia With Neurodevelopmental Outcomes at 4.5 Years , 2017, JAMA pediatrics.

[14]  Claudio Cobelli,et al.  Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial , 2017, Pediatrics.

[15]  D. Marikar,et al.  Definition and monitoring of neonatal hypoglycaemia: a nationwide survey of NHS England Neonatal Units , 2016, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[16]  Roman Hovorka,et al.  Continuous glucose control in the ICU: report of a 2013 round table meeting , 2014, Critical Care.

[17]  Ahmad Haidar,et al.  Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations. , 2014, Diabetes technology & therapeutics.

[18]  J. Chase,et al.  Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial , 2013, The Lancet.

[19]  Jeffrey C Murray,et al.  Hyperglycemia as a risk factor for the development of retinopathy of prematurity , 2013, BMC Pediatrics.

[20]  D. Klonoff,et al.  Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[21]  M Thio,et al.  Validation of the continuous glucose monitoring sensor in preterm infants , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[22]  D. Dunger,et al.  Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study. , 2010, The Journal of pediatrics.

[23]  K. Maher,et al.  Continuous glucose monitors prove highly accurate in critically ill children , 2010, Critical care.

[24]  K. Beardsall.  Measurement of glucose levels in the newborn. , 2010, Early human development.

[25]  Mikael Norman,et al.  Early Hyperglycemia Is a Risk Factor for Death and White Matter Reduction in Preterm Infants , 2010, Pediatrics.

[26]  Christopher R Palmer,et al.  Early insulin therapy in very-low-birth-weight infants. , 2008, The New England journal of medicine.

[27]  Smith Eo,et al.  Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. , 2006 .

[28]  B. Morris,et al.  Hyperglycemia and morbidity and mortality in extremely low birth weight infants , 2006, Journal of Perinatology.

[29]  D. Dunger,et al.  The continuous glucose monitoring sensor in neonatal intensive care , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[30]  Christoph U. Lehmann,et al.  Hyperglycemia and Retinopathy of Prematurity in Very Low Birth Weight Infants , 2003, Journal of Perinatology.

[31]  J. Yager.  Hypoglycemic injury to the immature brain. , 2002, Clinics in perinatology.

[32]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[33]  N. Barzilai,et al.  Glucose Regulates in Vivo Glucose-6-phosphatase Gene Expression in the Liver of Diabetic Rats (*) , 1996, The Journal of Biological Chemistry.

[34]  L. Finberg.  Dangers to infants caused by changes in osmolal concentration. , 1967, Pediatrics.